Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2190-9172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry ; volume:13 ; number:1 ; day:16 ; month:11 ; year:2022 ; pages:187-206 ; date:1.2023
Dermatology and therapy ; 13, Heft 1 (16.11.2022), 187-206, 1.2023
- Creator
-
Yu, Chen
Wang, Gang
Burge, Russel T.
Ye, Erjia
Dou, Guanshen
Li, Jinnan
Harrison, Ryan W.
McLean, Robert R.
Kerti, Samantha J.
Bagel, Jerry
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13555-022-00843-6
- URN
-
urn:nbn:de:101:1-2023031522131364116597
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yu, Chen
- Wang, Gang
- Burge, Russel T.
- Ye, Erjia
- Dou, Guanshen
- Li, Jinnan
- Harrison, Ryan W.
- McLean, Robert R.
- Kerti, Samantha J.
- Bagel, Jerry
- SpringerLink (Online service)
Other Objects (12)
Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis
The effects of quantitative easing announcements on the mortgage market: An event study approach
Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry
Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Dermal mesenchymal stem cells: a resource of migration-associated function in psoriasis?
Random exponential attractor for a stochastic reaction-diffusion equation in L 2 p ( D ) $L^2p}(D)$
Mirror patterns of physical variables in the ocean
Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis
The effects of quantitative easing announcements on the mortgage market: An event study approach
Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry
Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Dermal mesenchymal stem cells: a resource of migration-associated function in psoriasis?
Random exponential attractor for a stochastic reaction-diffusion equation in L 2 p ( D ) $L^2p}(D)$
Mirror patterns of physical variables in the ocean
Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis
The effects of quantitative easing announcements on the mortgage market: An event study approach
Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry
Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Dermal mesenchymal stem cells: a resource of migration-associated function in psoriasis?
Random exponential attractor for a stochastic reaction-diffusion equation in L 2 p ( D ) $L^2p}(D)$